4-CARBOXYAMINO-2-ETHYL-1,2,3,4-TETRAHYDROQUINOLINE CRYSTAL AS CETP INHIBITOR - Patent 1246804

(19)

(11)

EP 1 246 804 A1

(12)

(43)	Date of publication:
	09.10.2002 Bulletin 2002/41

(21)	Application number: 00971662.2

(22)	Date of filing: 14.11.2000

(51)	International Patent Classification (IPC)⁷: C07D 215/42, A61K 31/47, A61P 9/10

(86)	International application number:
	PCT/IB0001/650

(87)	International publication number:
	WO 0104/0190 (07.06.2001 Gazette 2001/23)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

30.11.1999 US 168051 P

(71)	Applicant: Pfizer Products Inc.
	Groton,Connecticut 06340 (US)

(72)	Inventors:
	ALLEN, Douglas, J. M.,Pfizer Global Rch. & Dev. Groton, CT 06340 (US) APPLETON, Troy, A.,Pfizer Global Rch. & Dev. Groton, CT 06340 (US) BROSTROM, Lyle, R.,Pfizer Global Rch. & Dev. Groton, CT 06340 (US) TICKNER, Derek, L.,Pfizer Global Rch. & Dev. Groton, CT 06340 (US)

(74)	Representative: Sewell, Richard Charles
	Pfizer Limited,European Patents Department,Ramsgate Road Sandwich,Kent CT13 9NJ Sandwich,Kent CT13 9NJ (GB)

(54)	4-CARBOXYAMINO-2-ETHYL-1,2,3,4-TETRAHYDROQUINOLINE CRYSTAL AS CETP INHIBITOR